Martin Michelle T, Kuchta Ann M, Nutescu Edith A
Department of Pharmacy Practice, University of Illinois at Chicago, College of Pharmacy, Chicago, IL 60612, USA.
J Pharm Pract. 2010 Aug;23(4):303-12. doi: 10.1177/0897190010363276. Epub 2010 May 7.
Updates in recent clinical guidelines have led to a change in the management of perioperative anticoagulation for patients on oral anticoagulant therapy. No standardized bridging consensus exists in the literature. The necessity for bridging therapy is determined based on careful consideration of the thrombosis risk versus the bleeding risk of the procedure. Risk stratification will aid the decision to bridge or not to bridge. Patients are bridged with agents with appropriate kinetics to allow for their elimination prior to the time of the procedure in order to decrease the risk of hemorrhage during invasive procedures. This intent of this article is to discuss perioperative bridging therapy and provide a practical guide for the clinician.
近期临床指南的更新导致了接受口服抗凝治疗患者围手术期抗凝管理的变化。文献中不存在标准化的桥接共识。桥接治疗的必要性是在仔细权衡手术的血栓形成风险与出血风险后确定的。风险分层将有助于决定是否进行桥接。患者使用具有适当动力学的药物进行桥接,以便在手术前将其清除,从而降低侵入性手术期间出血的风险。本文旨在讨论围手术期桥接治疗,并为临床医生提供实用指南。